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The development of tolerance to long-acting oral administered nitrates has 
been recognized. The ACE inhibitor has been to reported to reverse vascular 
tolerance to nitroglycerin (NTG). To investigate the effects of angiotensin 
converting enzyme (ACE) inhibitors on nitrate toterance, we measured coro- 
nanj artery diameter, platelet cyclic GMP and neurohormonal factors (plasma 
renin activity, norepinephdn level) In 60 consecutive patients undergoing rou- 
tine cardiac catheterization and coronary angiography before and 2 minutes 
after intracoronary injection of nitroglycerin 200/Jg, and compared among the 
following three groups: 1) 20 who had been lmated neither with nitrates nor 
enalapdl (controlgroup), 2) 20 patients heated with nitrates (nitrate group), 3) 
20 patients treated with both of nitrates and enalapdl (enalaptil group). The 
%increase in platelet cGMP in the nitrate group was sign'dicanUy less than that 
in the control group. The %increase in platelet cGMP in the enalapril group 
was also significantly less than that in the control group, but was signiflcanlly 
greater than that in the nitrate group. The %dilataUon of comnaly dilatation 
induced by nitroglycerin was significantly less in the nib'ate group than in 
the control group. That in the enalapril group was also significantly less tllan 
that in the control group, but was significantly greater than that in the nitrate 
group. PRA was significantly greater in the enalapril group than in the other 
two groups, but the %increase in PRA in the enalapdl group was not d~femnt 
from that in the nflmte group. NE and the %increaSe in NE were not different 
among the three groups. These results indicate that enalapdl prevents the 
attenuation of the intrace,ular production of cGMP during continuous nitrate 
therapy, and that enalapdl may be helpful as concomitant therapy to maintain 
the effect of nitrates in patients received Iong-acl~ng nitrates. 
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